Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis

BACKGROUND: Multiple sclerosis (MS) is the most common immune-mediated demyelinating disease in younger adults. Patients with MS (PwMS) are vulnerable to the presence of potential drug–drug interactions (pDDIs) and potential drug–food interactions (pDFIs) as they take numerous medications to treat M...

Descripción completa

Detalles Bibliográficos
Autores principales: Debus, Jane Louisa, Bachmann, Paula, Frahm, Niklas, Mashhadiakbar, Pegah, Langhorst, Silvan Elias, Streckenbach, Barbara, Baldt, Julia, Heidler, Felicita, Hecker, Michael, Zettl, Uwe Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358348/
https://www.ncbi.nlm.nih.gov/pubmed/35959503
http://dx.doi.org/10.1177/20406223221108391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358348/
https://www.ncbi.nlm.nih.gov/pubmed/35959503
http://dx.doi.org/10.1177/20406223221108391

Ejemplares similares